Affiliation:
1. The Johns Hopkins University School of Medicine, Baltimore, Maryland
Abstract
This cross-sectional study of US adults examines the geographical distribution of individuals eligible to participate in the Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity (SELECT) trial to estimate potential cardiovascular health impacts of implementing the trial findings at state and national levels.
Publisher
American Medical Association (AMA)
Reference6 articles.
1. Obesity and cardiovascular disease: a scientific statement from the American Heart Association.;Powell-Wiley;Circulation,2021
2. Semaglutide and cardiovascular outcomes in obesity without diabetes.;Lincoff;N Engl J Med,2023
3. Geographic variation in cardiovascular health among American adults.;Parcha;Mayo Clin Proc,2021
4. Eligibility for cardiovascular risk reduction therapy in the United States based on SELECT trial criteria: insights from the National Health and Nutrition Examination Survey.;Lu;Circ Cardiovasc Qual Outcomes,2024
5. US Census Bureau (Population Division). Annual Estimates of the Resident Population for the United States, Regions, States, District of Columbia, and Puerto Rico: April 1, 2020 to July 1, 2023 (NST-EST2023-POP). Revised December 18, 2023. Accessed February 1, 2024. https://www.census.gov/data/tables/time-series/demo/popest/2020s-state-total.html
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献